In This Article:
Over the last 7 days, the United States market has risen by 5.7%, contributing to a substantial climb of 37% over the past year, with earnings forecasted to grow by 16% annually. In this robust market environment, identifying small-cap stocks with insider action can be an intriguing approach for investors looking to uncover potential opportunities.
Top 10 Undervalued Small Caps With Insider Buying In The United States
Name | PE | PS | Discount to Fair Value | Value Rating |
---|---|---|---|---|
Thryv Holdings | NA | 0.7x | 47.74% | ★★★★★☆ |
HighPeak Energy | 10.8x | 1.6x | 37.99% | ★★★★★☆ |
Solo Brands | NA | 0.2x | 32.36% | ★★★★★☆ |
Hanover Bancorp | 10.8x | 2.3x | 43.02% | ★★★★☆☆ |
Franklin Financial Services | 10.2x | 2.0x | 32.84% | ★★★★☆☆ |
USCB Financial Holdings | 19.5x | 5.6x | 44.93% | ★★★☆☆☆ |
First United | 14.0x | 3.2x | 45.68% | ★★★☆☆☆ |
Orion Group Holdings | NA | 0.4x | -228.49% | ★★★☆☆☆ |
Community West Bancshares | 18.7x | 2.9x | 42.25% | ★★★☆☆☆ |
Delek US Holdings | NA | 0.1x | -69.24% | ★★★☆☆☆ |
Below we spotlight a couple of our favorites from our exclusive screener.
LifeMD
Simply Wall St Value Rating: ★★★★★★
Overview: LifeMD is a company that operates in the telehealth sector and also offers services through its Worksimpli segment, with a combined market capitalization of approximately $0.05 billion.
Operations: LifeMD generates revenue primarily from its Telehealth and Worksimpli segments, contributing $139.81 million and $53.25 million respectively. The company has seen a notable trend in its gross profit margin, reaching 89.64% as of September 2024. Operating expenses, including significant sales and marketing costs, impact the net income figures negatively despite high gross margins.
PE: -12.0x
LifeMD, a small company in the U.S., reported significant revenue growth to US$53.39 million for Q3 2024, up from US$38.61 million the previous year, despite remaining unprofitable with a net loss of US$5.13 million. Recent insider confidence is reflected in share purchases over the past year, suggesting potential value recognition by insiders. The launch of an integrated pharmacy enhances its telehealth platform and aims for annualized savings of about US$5 million, positioning LifeMD for future operational improvements and expansion opportunities within its sector.
-
Navigate through the intricacies of LifeMD with our comprehensive valuation report here.
-
Assess LifeMD's past performance with our detailed historical performance reports.
Mid Penn Bancorp
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Mid Penn Bancorp operates as a full-service commercial banking and trust business with a market cap of approximately $0.33 billion.